Nuciferine Prevents Hepatic Steatosis and Injury Induced by a High-Fat Diet in Hamsters

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Guo, Fuchuan ^a   Yang, Xue ^a   Li, Xiaoxia ^a   Feng, Rennan ^a   Guan, Chunmei ^a   Wang, Yanwen ^b,c   Li, Ying ^a   Sun, Changhao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APORPHINE DERIVATIVE; CHOLESTEROL; CYTOCHROME P450 2E1; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NUCIFERINE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DYSLIPIDEMIA; FATTY LIVER; FOOD INTAKE; GENE EXPRESSION; HAMSTER; LIPID DIET; LIPOGENESIS; LIPOLYSIS; LIVER INJURY; LIVER WEIGHT; MALE; METABOLIC SYNDROME X; NONHUMAN; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPLEMENTATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APORPHINES; BODY WEIGHT; CRICETINAE; DIETARY FATS; FATTY LIVER; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; LIVER; MALE; MESOCRICETUS; ORGAN SIZE; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION; WOUNDS AND INJURIES;

EID: 84877765616     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063770     Document Type: Article

References (38)

1. Fan JG, Farrell GC, (2009) Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 50: 204-210.
2. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, et al. (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37: 917-923.
3. Luo X, Chen B, Liu J, Yao S, (2005) Simultaneous analysis of N-nornuciferine, O-nornuciferine, nuciferine, and roemerine in leaves of Nelumbo nucifera Gaertn by high-performance liquid chromatography-photodiode array detection-electrospray mass spectrometry. Anal Chim Acta 538: 129-133.
4. Mukherjee PK, Mukherjee D, Maji AK, Rai S, Heinrich M, (2009) The sacred lotus (Nelumbo nucifera)- phytochemical and therapeutic profile. J Pharm Pharmacol 61: 407-422.
5. Huang B, Ban X, He J, Tong J, Tian J, et al. (2010) Hepatoprotective and antioxidant activity of ethanolic extracts of edible lotus (Nelumbo nucifera Gaertn.) leaves. Food Chemistry 120: 873-878.
6. Ono Y, Hattori E, Fukaya Y, Imai S, Ohizumi Y, (2006) Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. J Ethnopharmacol 106: 238-244.
7. Du H, You JS, Zhao X, Park JY, Kim SH, et al. (2010) Antiobesity and hypolipidemic effects of lotus leaf hot water extract with taurine supplementation in rats fed a high fat diet. J Biomed Sci 17Suppl 1: S42.
8. Huang CF, Chen YW, Yang CY, Lin HY, Way TD, et al. (2011) Extract of lotus leaf (Nelumbo nucifera) and its active constituent catechin with insulin secretagogue activity. J Agric Food Chem 59: 1087-1094.
9. Hu L, Xu W, Zhang X, Su J, Liu X, et al. (2010) In-vitro and in-vivo evaluations of cytochrome P450 1A2 interactions with nuciferine. J Pharm Pharmacol 62: 658-662.
10. Ma W, Lu Y, Hu R, Chen J, Zhang Z, et al. (2010) Application of ionic liquids based microwave-assisted extraction of three alkaloids N-nornuciferine, O-nornuciferine, and nuciferine from lotus leaf. Talanta 80: 1292-1297.
11. Kashiwada Y, Aoshima A, Ikeshiro Y, Chen YP, Furukawa H, et al. (2005) Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbo nucifera, and structure-activity correlations with related alkaloids. Bioorg Med Chem 13: 443-448.
12. Nguyen KH, Ta TN, Pham TH, Nguyen QT, Pham HD, et al. (2012) Nuciferine stimulates insulin secretion from beta cells-an in vitro comparison with glibenclamide. J Ethnopharmacol 142: 488-495.
13. Guo F, Huang C, Liao X, Wang Y, He Y, et al. (2011) Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters. Mol Nutr Food Res 55: 1809-1818.
14. Ahn J, Cho I, Kim S, Kwon D, Ha T, (2008) Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. J Hepatol 49: 1019-1028.
15. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321.
16. Folch J, Lees M, Sloane Stanley GH, (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
17. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
18. Bellentani S, Marino M, (2009) Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann Hepatol 8Suppl 1: S4-8.
19. Tailleux A, Wouters K, Staels B, (2012) Roles of PPARs in NAFLD: Potential therapeutic targets. Biochim Biophys Acta 1821: 809-818.
20. Choi MS, Lee MK, Jung UJ, Kim HJ, Do GM, et al. (2009) Metabolic response of soy pinitol on lipid-lowering, antioxidant and hepatoprotective action in hamsters fed-high fat and high cholesterol diet. Mol Nutr Food Res 53: 751-759.
21. Briand F, Thieblemont Q, Muzotte E, Sulpice T, (2012) High-Fat and Fructose Intake Induces Insulin Resistance, Dyslipidemia, and Liver Steatosis and Alters In Vivo Macrophage-to-Feces Reverse Cholesterol Transport in Hamsters. J Nutr 142: 704-709.
22. Basciano H, Miller AE, Naples M, Baker C, Kohen R, et al. (2009) Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis. Am J Physiol Endocrinol Metab 297: E462-473.
23. Wellen KE, Hotamisligil GS, (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112: 1785-1788.
24. Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, et al. (2004) Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 12: 962-971.
25. Stefan N, Kantartzis K, Haring HU, (2008) Causes and metabolic consequences of Fatty liver. Endocr Rev 29: 939-960.
26. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, et al. (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 278: 9073-9085.
27. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946.
28. Singhal NS, Patel RT, Qi Y, Lee YS, Ahima RS, (2008) Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. Am J Physiol Endocrinol Metab 295: E331-338.
29. Zhang YL, Hernandez-Ono A, Siri P, Weisberg S, Conlon D, et al. (2006) Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J Biol Chem 281: 37603-37615.
30. Lelliott CJ, Ljungberg A, Ahnmark A, William-Olsson L, Ekroos K, et al. (2007) Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation. Arterioscler Thromb Vasc Biol 27: 2707-2713.
31. Browning JD, Horton JD, (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114: 147-152.
32. Degrace P, Moindrot B, Mohamed I, Gresti J, Du ZY, et al. (2006) Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid. J Lipid Res 47: 2647-2655.
33. Lin MC, Gordon D, Wetterau JR, (1995) Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J Lipid Res 36: 1073-1081.
34. Nozaki Y, Fujita K, Yoneda M, Wada K, Shinohara Y, et al. (2009) Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease. J Hepatol 51: 548-556.
35. Adams LA, Angulo P, Lindor KD, (2005) Nonalcoholic fatty liver disease. CMAJ 172: 899-905.
36. Matsuzawa N, Takamura T, Kurita S, Misu H, Ota T, et al. (2007) Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46: 1392-1403.
37. Reddy JK, Rao MS, (2006) Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 290: G852-858.
38. Bhattacharya SK, Bose R, Ghosh P, Tripathi VJ, Ray AB, et al. (1978) Psychopharmacological studies on (-)-nuciferine and its Hofmann degradation product atherosperminine. Psychopharmacology (Berl) 59: 29-33.